ArticleDer Radiologe2012
[Radiotherapy of rectal cancer].
Article in Der Radiologe, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 3 citations in OpenAlex.
- [Local imaging of rectal cancer--update 2015: MRI as imaging biomarker].Der Radiologe · 2015Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
clinical issueDespite improved screening options, most patients with rectal cancer are diagnosed at a locally advanced disease stage. STANDARD TREATMENT/PRACTICAL RECOMMENDATIONS: The treatment strategy includes preoperative radiochemotherapy as a cornerstone in order to improve sphincter preservation and local control. It is evident that radiotherapy can achieve improved local control even if optimal surgery (total mesorectal excision TME) is performed. TREATMENT INNOVATIONS, FUTURE PROSPECTS: Whether the neoadjuvant therapy should be applied as a long-term or short-term schedule is controversially discussed. The benefit of newer agents to improve systemic control is still under investigation. Modern radiotherapy techniques increase the effectiveness of radiochemotherapy and may reduce therapy-associated toxicity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.